Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amedisys Inc (NQ: AMED )

103.76 -2.35 (-2.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 230,071
Open 104.89
Bid (Size) 102.93 (1)
Ask (Size) 104.37 (1)
Prev. Close 106.11
Today's Range 103.22 - 107.00
52wk Range 101.61 - 188.88
Shares Outstanding 32,631,959
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
Upgrades 
Via Benzinga
What 9 Analyst Ratings Have To Say About Amedisys
Over the past 3 months, 9 analysts have published their opinion on Amedisys (NASDAQ:AMED) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga

Performance

YTD
-37.28%
-37.28%
1 Month
-14.23%
-14.23%
3 Month
-9.46%
-9.46%
6 Month
-38.85%
-38.85%
1 Year
-33.55%
-33.55%

More News

Read More
Recap: Amedisys Q2 Earnings
Via Benzinga
Analyst Ratings for Amedisys
Via Benzinga
7 Analysts Have This to Say About Amedisys
Via Benzinga
Analyst Ratings For Amedisys
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2022
Via Benzinga
67 Biggest Movers From Yesterday
Via Benzinga
Stephens & Co. Maintains Equal-Weight Rating for Amedisys: Here's What You Need To Know
Via Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Via Benzinga
Analyst Ratings for Amedisys
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
Via Benzinga
Where Amedisys Stands With Analysts
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2022
Via Benzinga
Amedisys: Q4 Earnings Insights
Via Benzinga
The U.S. Home Health Care Industry Is Reportedly Booming As Seniors Overwhelmingly Want To Live At Home
Via Benzinga
This Company Just Made a Possibly Lucrative Acquisition — What's Next?
Via Benzinga
10 Bargain Stocks to Buy After Falling 30% in 2021
Via InvestorPlace
This Home Medical Company Looks to Be Moving Fast — What's Next?
Via Benzinga
Best Undervalued Health Care Companies You Never Heard Of
Via Talk Markets
This Industry, Important for Quality of Life, Is Big Business
Via Benzinga
Global Home Medical Equipment Market Size Is Estimated To Reach $56 Billion By 2027
Via FinancialNewsMedia
What 12 Analyst Ratings Have To Say About Amedisys
Via Benzinga
Amedisys, inc (AMED) Q3 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.